State of Wisconsin Investment Board

The State of Wisconsin Investment Board (SWIB) is a state agency responsible for managing the investment assets of the Wisconsin Retirement System (WRS), the State Investment Fund, and several smaller trust funds. SWIB's investment portfolio includes a diverse range of asset classes, with significant allocations to public equities, fixed income, real estate, private equity, and multi-asset strategies. Investment decisions are made by SWIB's professional staff and external money managers, who are obligated to prioritize the interests of WRS members. As fiduciaries, SWIB staff and Trustees apply rigorous diligence and care when managing these funds, ensuring that both risk and potential returns are thoroughly evaluated. The agency employs a value-oriented investment approach, utilizing fundamental research and tactical asset allocation strategies. Established in 1951 and based in Madison, Wisconsin, SWIB's mission is to enhance the financial security of its beneficiaries through prudent investment management.

Charles R. Carpenter

Managing Director, Private Markets

John Culley

Associate Portfolio Manager

Anne-Marie Fink

Managing Director, Private Markets

Rochelle Klaskin

Deputy Executive Director/Chief Administrative Officer

Villa CFA, CPA, David C.

Chief Investment Officer

37 past transactions

Neurovance

Venture Round in 2012
Neurovance, Inc., a neuroscience-focused company, focuses on the development and commercialization of therapies for adult and children with attention deficit hyperactivity disorders. The company develops centanafadine, a triple reuptake inhibitor that modulates the activity of norepinephrine dopamine and serotonin in a specific ratio. Neurovance, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. As of March 31, 2017, Neurovance, Inc. operates as a subsidiary of Otsuka America, Inc..

HistoSonics

Series C in 2020
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

EatStreet

Series C in 2015
EatStreet is an online and mobile food ordering service that streamlines commerce between restaurants and diners. To college students and young professionals, EatStreet is a smart, simple, and affordable way to order delivery and takeout from their favorite restaurants. To restaurant owners, EatStreet is a one-stop-shop for online ordering and marketing. By providing web, mobile, and social products for online ordering, EatStreet brings in new business for restaurants. Diners enjoy the upside of fast, simple ordering while restaurants see their sales soar. Founded in 2010, the company is headquartered in Madison, Wisconsin, United States.

Roche NimbleGen

Series D in 2003
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

Pinstripe

Series A in 2005
Pinstripe is a top RPO provider with global reach and high customer satisfaction as recognized by HRO Today’s Baker’s Dozen. They serve world-class organizations in financial services, healthcare, pharmaceuticals, technology, advanced manufacturing, biotech, telecommunications and energy.

FluGen

Venture Round in 2016
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

FluGen

Series A in 2017
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

Zystor

Series A in 2004
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.

Physiq

Private Placement in 2017
physIQ has developed a personalized physiology analytic platform (PPA) for use in both the regulated healthcare market as well as the unregulated health and fitness market. The technology is designed to detect subtle changes in vital signs and other health indicators to help clinicians manage patients with chronic illness, and to help consumers track their own health and fitness levels. The key differentiator between the physIQ platform and other technologies is that it constructs a personalized baseline norm for each person monitored, rather than simple trending or comparison to population-based statistics. Our technology can also be embedded into patient monitoring devices from other manufacturers who are seeking to design "smarter" products.

Montage

Series B in 2012
Montage Talent, Inc. provides live and on-demand voice and video interviewing solutions for large enterprises, healthcare industries, and staffing and recruitment process outsourcing vendors. Montage Talent, Inc. was formerly known as Expressume, Inc. and changed its name to Montage Talent, Inc. in May 2001. The company was founded in 2007 and is based in Delafield, Wisconsin. As of May 21, 2019, Montage Talent, Inc. operates as a subsidiary of Shaker International.

Mithridion

Series B in 2009
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer's disease and schizophrenia.

Datica

Venture Round in 2014
Datica helps highly regulated industries manage sensitive information in the cloud. Datica's customers ranges from mid-to-late-stage startups to Fortune 100 companies. The company was founded in 2013 and is based in Minneapolis, Minnesota.

HistoSonics

Private Placement in 2019
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

Elephas

Series C in 2023
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.

Elephas

Series C in 2024
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.

HistoSonics

Convertible Note in 2022
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

NeuWave Medical

Series B in 2012
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

HealthMyne

Private Placement in 2018
HealthMyne, Inc., a healthcare informatics company, provides novel search, analytics, and imaging solutions to healthcare enterprises. It focuses on providing solutions to cancer care providers. The company’s smart imaging solutions deliver clinical decision support and quality assurance services to reduce diagnostic errors and increase clinical collaboration. Its technology provides physicians with tumor image manipulation, and EHR and image repository search capabilities for diagnosing and treating similar cases. HealthMyne, Inc. was founded in 2013 and is based in Madison, Wisconsin.

NeuWave Medical

Series C in 2015
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

Invenra

Private Placement in 2018
Invenra Inc. engages in discovering biologics with a focus on antibodies and their derivatives. Its technology combines the cell-free expression of full-length antibodies and extreme miniaturization, enabling the screening of full-length antibodies in phenotypic assays. The company was founded in 2011 and is based in Madison, Wisconsin.

Madison Vaccines

Series A in 2015
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

HistoSonics

Private Placement in 2020
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

EatStreet

Series B in 2014
EatStreet is an online and mobile food ordering service that streamlines commerce between restaurants and diners. To college students and young professionals, EatStreet is a smart, simple, and affordable way to order delivery and takeout from their favorite restaurants. To restaurant owners, EatStreet is a one-stop-shop for online ordering and marketing. By providing web, mobile, and social products for online ordering, EatStreet brings in new business for restaurants. Diners enjoy the upside of fast, simple ordering while restaurants see their sales soar. Founded in 2010, the company is headquartered in Madison, Wisconsin, United States.

OpGen

Series B in 2005
OpGen, Inc is a privately-held company, based in Gaithersburg, MD, and focused on commercializing rapid, high precision solutions for DNA analysis and genomics with the Argus® Whole Genome Mapping System and MapIt® Services. Using the proprietary technologies provided by OpGen, customers in academic, government, biodefense and research labs as well as premier genome centers around the world can view ordered whole genome maps for a wide range of applications including strain typing for early outbreak response, improved sequence assembly of microbial and now large genomes up to 3 Gb and comparative genomics applications. OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.

Cardiac Pathways Corp

Venture Round in 2000
Cardiac Pathways Corp manufactures minimally-invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmia (abnormally rapid heart rhythms), which if untreated can cause palpitations, fainting, and sudden cardiac arrest. Cardiac Pathways' products consist principally of systems for performing ablation treatment (a nonsurgical, minimally-invasive technique for neutralizing heart tissue responsible for starting or maintaining a tachyarrhythmia) and for diagnostic mapping (locating the source of the tachyarrhythmia within the heart). Cardiac Pathways was issued a U.S. patent related to its Real-time Position Management Tracking System. Founded in 1991, Cardiac Pathways is based in Sunnyvale, California. As of August 6, 2001, it was acquired by Boston Scientific Corporation.

Zurex Pharma

Series B in 2014
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Rentable

Venture Round in 2015
Rentable is an internet company that specializes in providing a web-based platform that allows its users to conduct an online internet apartment search. The company was established in 2011 and is based in Madison, Wisconsin.

Neurovance

Series A in 2014
Neurovance, Inc., a neuroscience-focused company, focuses on the development and commercialization of therapies for adult and children with attention deficit hyperactivity disorders. The company develops centanafadine, a triple reuptake inhibitor that modulates the activity of norepinephrine dopamine and serotonin in a specific ratio. Neurovance, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. As of March 31, 2017, Neurovance, Inc. operates as a subsidiary of Otsuka America, Inc..

US Self-Storage Portfolio

Merger/Acquisition in 2018
US Self-Storage Portfolio comprises self-storage assets. The asset is located in the United States.

Madison Vaccines

Series A in 2014
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Lowe's Home Improvement Store In Torrance, California

Merger/Acquisition in 2018
Lowe's Home Improvement Store In Torrance, California comprises a retail property. The property is located in the United States.

Roche NimbleGen

Series B in 2001
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

Zurex Pharma, Inc.

Private Placement in 2018
Zurex Pharma, Inc., a pharma and medical technology company, develops and commercializes antimicrobial products to prevent health care-associated infections on surgical site wounds and catheter-related infections. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of surgical site infections; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound. The company was incorporated in 2008 and is based in Middleton, Wisconsin. Zurex Pharma, Inc. operates as a subsidiary of Ash Access Technology, Inc.

FluGen

Series A in 2015
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

Understory

Private Placement in 2018
Understory, Inc. provides real time datasets and graphical views of the movement and intensity of weather events. It builds, installs, maintains, and harvests data networks in Kansas City and northeast Dallas. The company offers precision hail, hail forensic, and precision wind reports for advanced property level analytics; and weather verification reports that include precipitation date, precipitation event, ice dam conditions, and wind event reports. It serves insurance companies, and property owners and managers; and students and staff at degree-granting institutions, including high schools, undergraduate colleges and universities, and post-graduate degree programs. Understory, Inc. was formerly known as Winstruments, Inc. The company was incorporated in 2012 and is based in Madison, Wisconsin.

Datica

Series A in 2013
Datica helps highly regulated industries manage sensitive information in the cloud. Datica's customers ranges from mid-to-late-stage startups to Fortune 100 companies. The company was founded in 2013 and is based in Minneapolis, Minnesota.